Ida Vanessa Döederlein Schwartz
Researcher Next ID · RN-037885
Researcher · Biochemistry, Genetics and Molecular Biology
Universidade Federal do Rio Grande do Sul
Porto Alegre, Brazil
- Works count
- 619
- Citation count
- 7,959
- H-index
- 47
- i10-index
- 180
Research interests
Publications
Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome
Annals of the Rheumatic Diseases · 2022 · 10.1136/annrheumdis-2022-222629
Gender, Race and Parenthood Impact Academic Productivity During the COVID-19 Pandemic: From Survey to Action
Frontiers in Psychology · 2021 · https://doi.org/10.3389/fpsyg.2021.663252
Impact of COVID-19 on academic mothers
Science · 2020 · https://doi.org/10.1126/science.abc2740
Parent in Science: The Impact of Parenthood on the Scientific Career in Brazil
· 2019 · 10.1109/ge.2019.00017
Phenotype, treatment practice and outcome in the cobalamin‐dependent remethylation disorders and MTHFR deficiency: Data from the E‐HOD registry
Journal of Inherited Metabolic Disease · 2019 · 10.1002/jimd.12041
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
Scientific Reports · 2018 · 10.1038/s41598-018-27315-2
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians
Molecular Genetics and Metabolism · 2017 · 10.1016/j.ymgme.2017.08.002
Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
American Journal of Hematology · 2017 · 10.1002/ajh.24957
Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review
Orphanet Journal of Rare Diseases · 2010 · 10.1186/1750-1172-5-14
Evidence that l-Carnitine and Selenium Supplementation Reduces Oxidative Stress in Phenylketonuric Patients
Cellular and Molecular Neurobiology · 2010 · 10.1007/s10571-010-9636-3
Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long‐term pulmonary function in patients treated with recombinant human N‐acetylgalactosamine 4‐sulfatase
Journal of Inherited Metabolic Disease · 2010 · 10.1007/s10545-009-9007-8
Multidisciplinary Management of Hunter Syndrome
PEDIATRICS · 2009 · https://doi.org/10.1542/peds.2008-0999
l-Carnitine Blood Levels and Oxidative Stress in Treated Phenylketonuric Patients
Cellular and Molecular Neurobiology · 2008 · 10.1007/s10571-008-9313-y
Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
Molecular Genetics and Metabolism · 2008 · https://doi.org/10.1016/j.ymgme.2008.04.001
Mucopolysaccharidoses in Brazil: What happens from birth to biochemical diagnosis?
American Journal of Medical Genetics Part A · 2008 · 10.1002/ajmg.a.32320
A clinical study of 77 patients with mucopolysaccharidosis type II
Acta Paediatrica · 2007 · 10.1111/j.1651-2227.2007.00212.x
Brain MRI in mucopolysaccharidosis
Neurology · 2007 · 10.1212/01.wnl.0000269782.80107.fe
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
The Journal of Pediatrics · 2006 · https://doi.org/10.1016/j.jpeds.2005.12.014
Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
American Journal of Medical Genetics Part A · 2005 · 10.1002/ajmg.a.30579
Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses
Journal of Inherited Metabolic Disease · 2004 · 10.1007/s10545-005-0069-y
CNS involvement in Fabry disease: Clinical and imaging studies before and after 12 months of enzyme replacement therapy
Journal of Inherited Metabolic Disease · 2004 · 10.1023/b:boli.0000028794.04349.91
Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses
Journal of Inherited Metabolic Disease · 2004 · 10.1007/s10545-005-5673-3
Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI
Clinical Genetics · 2004 · 10.1111/j.1399-0004.2004.00277.x
Development and Testing of New Screening Method for Keratan Sulfate in Mucopolysaccharidosis IVA
Pediatric Research · 2004 · 10.1203/01.pdr.0000113767.60140.e9
Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients
Molecular Genetics and Metabolism · 2003 · 10.1016/s1096-7192(02)00200-7
Current projects
No projects listed.